Announcements Trials
Browse Landscape

Phase

Phase NA 15Phase 1 10Phase 3 7Phase 2 5Phase 1/2 3Phase 2/3 1

Status

Completed 294Recruiting 146Terminated 141Unknown 79Active not recruiting 67Withdrawn 38Not yet recruiting 33Suspended 3Enrolling by invitation 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 14Other hematologic neoplasm 7Lymphoid 6Dermatologic 5Tumor-Agnostic 4Thoracic 4CNS 4Other solid neoplasm 3Myeloid 3Genitourinary 3Breast 3Sarcoma 2Plasma cell 2Gynecologic 2NET 1Endocrine 1

Conditions

Breast Neoplasms 3Vulvar Neoplasms 1Vaginitis 1Sarcoma 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Gallbladder Neoplasms 1Dyspareunia 1Carcinoma, Neuroendocrine 1Bile Duct Neoplasms 1

Interventions

tivozanib 1palbociclib 1atezolizumab 1Testosterone Propionate 1Testosterone 1Lisaftoclax 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Suspended × Breast × Clear all
NCT05000294 2026-02-18

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

University of Florida

Phase 1/2 Suspended
29 enrolled
BreastEndocrineGastrointestinalGenitourinaryGynecologicNETSarcoma

Bile Duct Neoplasms, Breast Neoplasms, Gallbladder Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vulvar Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT04946864 2024-08-19

A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer

Ascentage Pharma Group Inc.

Phase 1/2 Suspended
65 enrolled
Breast

Breast Neoplasms

NCT01122342 2010-05-13

Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.

University of Vermont

Phase 1/2 Suspended
30 enrolled
Breast

Breast Neoplasms, Dyspareunia, Vaginitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡